Mumbai: RPG Life Sciences Limited, the pharmaceutical arm of the RPG Group, today announced the appointment of Amol Lone as its Chief Financial Officer, effective immediately. The appointment was approved by the company’s Board of Directors at its meeting held on December 15, 2025.
In his new role, Lone will be responsible for overseeing all financial operations, strategic planning, and compliance functions at RPG Life Sciences. He brings over two decades of experience in corporate finance, having held senior leadership roles across multinational organisations including Gunnebo India Ltd, Henkel Adhesives, Teva Pharmaceuticals, and Fermenta Biotech Ltd.
A qualified chartered accountant, Lone has deep expertise spanning direct and indirect taxation, treasury management, debt restructuring, and regulatory compliance, positioning him to support the company’s financial and growth ambitions.
Commenting on the appointment, Ashok Nair, Managing Director of RPG Life Sciences, said, “We are pleased to welcome Amol to RPG Life Sciences. His extensive financial acumen and regulatory expertise will strengthen our growth trajectory in a dynamic landscape.”
Amol Lone said, “I am excited to join RPG Life Sciences as it prepares for its next transformative phase. With focus on expanding niche therapies, nurturing innovation, and accelerating growth, I look forward to contributing to this journey.”
